Covid-19 Vaccine Development: A Global Effort to Overcome the Pandemic

Strategic Insights -

The world is witnessing a mass effort to develop effective Covid-19 vaccines, with several promising candidates in the final stages of testing. Pfizer, Moderna, and the University of Oxford / AstraZeneca are among the leading players in the vaccine development race, with the UK's Vaccine Taskforce securing a total of 355 million vaccine doses from seven different candidates. The Oxford vaccine has shown a 70% efficacy rate in preventing Covid symptoms, while the Pfizer and Moderna jabs have reported 90% and 95% efficacy rates, respectively. As the world waits for approval, words of caution have been expressed, highlighting the need for rigorous testing and regulatory approval.

Key Takeaways:

  • **Seven vaccine candidates**: The UK's Vaccine Taskforce has secured a total of 355 million vaccine doses from seven different candidates, including Oxford / AstraZeneca, Imperial, Pfizer / BioNTech, Moderna, Janssen, Valneva, and Novavax.
  • **Efficacy rates**: The Oxford vaccine has shown a 70% efficacy rate in preventing Covid symptoms, while the Pfizer and Moderna jabs have reported 90% and 95% efficacy rates, respectively.
  • **Pfizer's production plans**: Pfizer aims to produce 1.3 billion doses of its Covid vaccine throughout 2021.
  • **Moderna's production plans**: Moderna will provide the UK with five million doses of its vaccine by spring 2021.
  • **Janssen's clinical trials**: Janssen has just begun clinical trials in the UK and is expected to form part of the government's first wave of vaccine rollout by mid-2021.
  • **Global vaccine development**: Hundreds of vaccines are in development worldwide, including ones from Russia's Gamaleya Research Institute and China's Wuhan Institute of Biological Products and Sinopharm.
  • **UK's Vaccine Taskforce**: The taskforce has secured rights to AstraZeneca's antibody treatment to neutralize the virus.
  • **Oxford vaccine's manufacturing**: The Oxford vaccine is said to be easier to manufacture than other vaccines, which could make it available faster once approved.
  • **UK's vaccine rollout**: The UK aims to make 100 million doses of vaccine available, with priority groups receiving it early next year.

Statistics:

  • **355 million vaccine doses secured**: The UK's Vaccine Taskforce has secured a total of 355 million vaccine doses from seven different candidates.
  • **1.3 billion doses planned**: Pfizer aims to produce 1.3 billion doses of its Covid vaccine throughout 2021.
  • **30 million doses procured**: The UK has procured 30 million doses of the Pfizer vaccine in 2021.
  • **5 million doses planned**: Moderna will provide the UK with five million doses of its vaccine by spring 2021.
  • **100 million doses planned**: The UK aims to make 100 million doses of vaccine available, with priority groups receiving it early next year.

Sources:

  • https://www.scotsman.com/health/coronavirus/can-i-volunteer-covid-vaccine-trial-how-sign-test-janssen-oxford-and-novavax-jabs-and-if-you-get-paid-3037250
  • https://www.scotsman.com/health/coronavirus/sir-john-bell-who-regius-professor-and-member-government-vaccine-taskforce-and-why-does-he-think-life-will-be-normal-spring-3031650
  • https://www.scotsman.com/health/how-long-do-covid-antibodies-last-why-boris-johnson-self-isolating-again-and-if-you-can-get-coronavirus-more-once-3037619